We anticipate to see strong growth in robotic surgery across all specialties. Within orthopedic surgery, we have really seen dramatic growth in total knee replacements over the last two years, especially after the approval of Stryker's Mako Total Knee application. This growth will continue as we're still in the early stages of adoption of robotic total knee replacements. And as our strong midterm to long-term clinical data begins to roll in, we're going to see adoption of robotic total knee procedures, both in the U.S. and also in international markets as well.

Within the general surgery space, as more surgeons become familiar with the robotic system, we're going to see penetration into the more complex general surgical procedures. For example, complex hernia repairs with component separation, lower anterior resections, and even complex hepatobiliary resections. All these procedures can be quite risky when done open or laparoscopically which is where robotics can bring a lot of value to these procedures.

And finally, let's not forget the emergence of endoluminal surgical robotics and its immediate application to lung cancer detection. As we all know, lung cancer is one of the leading causes of cancer death across the world. Robotic technology introduces less invasive method to perform lung biopsies deep within the lung, which can sometimes be very dangerous to perform using conventional methods.

A look ahead: Medical aesthetics market recovery in 2021 and beyond

View Now